About: A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Two hundred nine patients with active rheumatoid arthritis, who were receiving methotrexate for at least 6 months, were randomized in a double-blind fashion to receive: placebo and three doses of interferon-? administered in subcutaneous injections for the duration of 24 weeks. At the doses tested, treatment with IFN-3 times weekly did not induce a clinical or radiological effect in RA patients Two hundred nine patients with active rheumatoid arthritis, who were receiving methotrexate for at least 6 months, were randomized in a double-blind fashion to receive: placebo and three doses of interferon-? administered in subcutaneous injections for the duration of 24 weeks. At the doses tested, treatment with IFN-3 times weekly did not induce a clinical or radiological effect in RA patients (en)
Title	A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis (en)
skos:prefLabel	A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis (en)
skos:notation	RIV/00023728:_____/05:00000230!RIV10-MZ0-00023728
http://linked.open...avai/riv/aktivita	V
http://linked.open...avai/riv/aktivity	V
http://linked.open...iv/cisloPeriodika	1
http://linked.open...vai/riv/dodaniDat	2010
http://linked.open...aciTvurceVysledku	Pavelka, Karel Vencovský, Jiří
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Revmatologický ústav
http://linked.open...dnocenehoVysledku	510918
http://linked.open...ai/riv/idVysledku	RIV/00023728:_____/05:00000230
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	multicentre; randomised; double; blind; placebo; controlled; phase; study; subcutaneous; interferon; beta-1a; treatment; patients; active; rheumatoid; arthritis (en)
http://linked.open.../riv/klicoveSlovo	placebo phase patients subcutaneous controlled double blind arthritis randomised study treatment rheumatoid active interferon multicentre beta-1a
http://linked.open...odStatuVydavatele	GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV	[87A9FA680F13]
http://linked.open...i/riv/nazevZdroje	Annals of Rheumatic Diseases
http://linked.open...in/vavai/riv/obor	FE
http://linked.open...ichTvurcuVysledku	2 (xsd:int)
http://linked.open...cetTvurcuVysledku	14 (xsd:int)
http://linked.open...UplatneniVysledku	2005
http://linked.open...v/svazekPeriodika	64
http://linked.open...iv/tvurceVysledku	Pavelka, Karel Rozman, B. Vencovský, Jiří Tak, P. P. Herrero-Beaumont, G. Alvaro, J. Furst, D. Genovese, M. Kivitz, A. J. McInnes, I. B. Musikic, P. Nuki, G. Stahl, H. Van Holten, J.
http://linked.open...ain/vavai/riv/wos	000225800100014
issn	0003-4967
number of pages	6 (xsd:int)
is http://linked.open...avai/riv/vysledek of	A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 35 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software